Louisiana State Employees Retirement System bought a new stake in shares of Xylem Inc. (NYSE:XYL – Free Report) during the first quarter, HoldingsChannel.com reports. The fund bought 12,400 shares of the industrial products company’s stock, valued at approximately $1,482,000.
Other institutional investors and hedge funds have also recently modified their holdings of the company. J. Stern & Co. LLP grew its position in Xylem by 12,326.6% in the 4th quarter. J. Stern & Co. LLP now owns 45,448,168 shares of the industrial products company’s stock valued at $6,189,132,000 after acquiring an additional 45,082,435 shares during the last quarter. Vanguard Group Inc. grew its holdings in shares of Xylem by 0.5% in the fourth quarter. Vanguard Group Inc. now owns 30,054,743 shares of the industrial products company’s stock worth $4,092,855,000 after purchasing an additional 152,507 shares during the last quarter. State Street Corp increased its stake in Xylem by 2.6% in the 4th quarter. State Street Corp now owns 11,233,427 shares of the industrial products company’s stock worth $1,529,768,000 after buying an additional 280,221 shares during the period. Geode Capital Management LLC increased its stake in Xylem by 2.4% in the 4th quarter. Geode Capital Management LLC now owns 6,357,278 shares of the industrial products company’s stock worth $862,364,000 after buying an additional 151,754 shares during the period. Finally, Swedbank AB lifted its holdings in Xylem by 6.0% during the 4th quarter. Swedbank AB now owns 5,507,966 shares of the industrial products company’s stock valued at $750,075,000 after buying an additional 310,213 shares in the last quarter. 87.96% of the stock is owned by institutional investors.
Xylem Stock Performance
Shares of XYL stock opened at $118.22 on Friday. The firm has a market cap of $28.10 billion, a price-to-earnings ratio of 29.41, a PEG ratio of 1.67 and a beta of 1.03. Xylem Inc. has a 52-week low of $105.29 and a 52-week high of $154.27. The company has a quick ratio of 1.10, a current ratio of 1.46 and a debt-to-equity ratio of 0.13. The company’s 50 day moving average is $112.72 and its 200 day moving average is $124.71.
Xylem Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Thursday, June 25th. Investors of record on Thursday, May 28th were paid a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.5%. The ex-dividend date was Thursday, May 28th. Xylem’s dividend payout ratio is 42.79%.
Insider Transactions at Xylem
In related news, CAO Geri-Michelle Mcshane sold 4,269 shares of the firm’s stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $117.46, for a total transaction of $501,436.74. Following the sale, the chief accounting officer owned 3,605 shares of the company’s stock, valued at $423,443.30. This trade represents a 54.22% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Jerome A. Peribere bought 1,210 shares of the business’s stock in a transaction on Monday, May 4th. The stock was bought at an average price of $116.61 per share, for a total transaction of $141,098.10. Following the purchase, the director directly owned 27,209 shares of the company’s stock, valued at $3,172,841.49. The trade was a 4.65% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 0.32% of the stock is owned by company insiders.
Wall Street Analysts Forecast Growth
Several equities research analysts have issued reports on the stock. Stifel Nicolaus lowered their price objective on shares of Xylem from $163.00 to $159.00 and set a “buy” rating for the company in a research report on Wednesday, April 29th. CLSA raised shares of Xylem to a “hold” rating in a research report on Thursday, June 25th. Barclays decreased their price target on shares of Xylem from $156.00 to $154.00 and set an “overweight” rating for the company in a research note on Wednesday, April 29th. Oppenheimer dropped their price objective on Xylem from $160.00 to $158.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 29th. Finally, Citigroup reduced their price objective on Xylem from $174.00 to $168.00 and set a “buy” rating on the stock in a report on Wednesday, April 29th. Eight research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Xylem currently has an average rating of “Moderate Buy” and an average price target of $153.54.
Check Out Our Latest Stock Report on Xylem
About Xylem
Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.
The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.
Featured Articles
- Five stocks we like better than Xylem
- Shorting the Grid: Bloom Energy’s $25B AI Power Play
- SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
- Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
- 3 Dividend ETFs Built for Stability in a Volatile Market
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
